Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN118184591A offers cost-effective synthesis for TYK2 inhibitor intermediates with high purity and scalable processes for global supply chains.
Patent CN115215810B reveals catalyst-free heating method. Reduces cost and supply chain risk for pharma intermediates. High purity and scalability.
Novel metal-free sulfur-promoted method for high-purity triazole intermediates. Reduces cost and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN111978265B reveals a robust FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel sulfur-mediated cyclization offers cost-effective route for high-purity API intermediates. Eliminates heavy metals for scalable commercial production.
Novel Pd-catalyzed pathway reduces costs for chroman amides. Enhances supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN111087344A discloses a green synthesis for diaziridine-amino acid conjugates. This report analyzes the scalable route for high-purity pharmaceutical intermediates.
Novel palladium-catalyzed synthesis method for isoquinoline ketones offering high efficiency and substrate compatibility for pharmaceutical intermediate manufacturing supply chains.
Novel Pd-catalyzed multicomponent route for indolinone-imidazole scaffolds offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN113045503A reveals a novel palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation method enhances purity and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN111662158A discloses a robust method for axial chiral biaryl and fluorenol synthesis using Pd/norbornene catalysis, offering high enantioselectivity and supply chain reliability.
Novel silver catalyst enables high-yield asymmetric synthesis for pharmaceutical intermediates with improved supply chain reliability and cost efficiency.
Patent CN112480015B reveals a novel Pd-catalyzed one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed oxidation process enables high-yield production. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Novel rare earth catalyzed method for aromatic formamide and olefin. Offers mild conditions and high purity for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for quinolinones. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering significant cost reduction in API manufacturing and scalable production.
Patent CN115536605B details iridium-catalyzed oxazole synthesis enabling efficient COX-2 inhibitor production with reduced steps and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN113735778B enables efficient synthesis of 5-trifluoromethyl imidazole. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.